Aug 28, 09:07
AnnouncementsSanofi partners with Emcure Pharmaceuticals
100% of moneycontrol users recommend buying Sanofi India.
What's your call on Sanofi India today?
Read Investor view
|Company Name||Last Price||%
|Dr Reddys Labs||2951.10||0.96||2969.00||2286.80||50,267.57|
|Mar' 14||Dec' 13||Sep' 13||Jun' 13|
|Scheme||No. of Shares|
|Reliance Equity Opportunities Fund - Retail Plan (G)||582,022|
|Reliance Pharma Fund (G)||263,152|
|UTI Mastershare (G)||197,441|
|Reliance Tax Saver (ELSS) Fund (G)||176,183|
RS Software (India) Recommended on Aug 12th 2014
Recommended price 430.00 | Peak from reco 585.50 36.16%
What are Multi baggers?
Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.
Sanofi India is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 6,980.58 crore.The company has reported a standalone sales of Rs 486.70 crore and a Net Profit of Rs 57.50 crore for the quarter ended Jun 2014.
The company management includes Vijay Mallya - Chairman, Shailesh Ayyangar - Managing Director, F Briens - Director, Virginie Boucinha - Director, J M Georges - Director, S R Gupte - Director, Rangaswamy R lyer - Director, A K R Nedungadi - Director, A Ortoli - Director, M G Rao - Alternate Director.
It is listed on the BSE with a BSE Code of 500674 and the NSE with an NSE Code of SANOFI.
Its Registered office is at Aventis House, 54/A, Sir Mathuradas Vasanji Road,,Andheri (East) Mumbai,Maharashtra - 400093.
Their Registrars are Link Intime India Pvt. Ltd.